Piramal Pharma has an ambitious roadmap to nearly double revenues. TP ₹295 (53% upside)

Discussion in 'Latest Brokerage Stock Buy-Sell Reports' started by Vidhi Khanna, Aug 21, 2025 at 8:35 PM.

  1. Vidhi Khanna

    Vidhi Khanna Active Member Staff Member

    Joined:
    Mar 19, 2015
    Messages:
    995
    Likes Received:
    55
Loading...